Home Applications 207131 Application 207131
Type NDA
Sponsor BAXTER HLTHCARE CORP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CEFAZOLIN IN PLASTIC CONTAINER CEFAZOLIN SODIUM SOLUTION;INTRAVENOUS EQ 2GM BASE/100ML (EQ 20MG BASE/ML) No No 002 CEFAZOLIN IN PLASTIC CONTAINER CEFAZOLIN SODIUM SOLUTION;INTRAVENOUS EQ 1GM BASE/50ML (EQ 20MG BASE/ML) Yes Yes 003 CEFAZOLIN IN DEXTROSE CEFAZOLIN SODIUM SOLUTION;INTRAVENOUS EQ 3GM BASE/150ML (EQ 20MG BASE/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N207131-001 CEFAZOLIN IN DEXTROSE CEFAZOLIN SODIUM EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 N207131-002 CEFAZOLIN IN DEXTROSE CEFAZOLIN SODIUM EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 N207131-003 CEFAZOLIN IN DEXTROSE CEFAZOLIN SODIUM EQ 3GM BASE/150ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2024-05-31
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 101 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 e64feba35796…2022-09-29 23:25 UTC 2022-09 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N207131-001 CEFAZOLIN IN PLASTIC CONTAINER EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N207131-002 CEFAZOLIN IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N207131-001 CEFAZOLIN IN DEXTROSE EQ 2GM BASE/100ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2015-08-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N207131-002 CEFAZOLIN IN DEXTROSE EQ 1GM BASE/50ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-02-01 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N207131-003 CEFAZOLIN IN DEXTROSE EQ 3GM BASE/150ML (EQ 20MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2024-05-31 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0338-3503 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3503 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3503 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3508 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3508 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3508 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3508 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3508 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3508 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current 0338-3508 Cefazolin Cefazolin Sodium Baxter Healthcare Corporation NDA Current